Showing results (631-640 of 651) with videos related to

Sort By:
Pageof 66
Transplantation and Cellular Therapy|October 13, 2024
Addition of Nivolumab Tailored by Expansion of CAR-T Cells in Patients with Stable/Progressive Large B Cell Lymphoma at Lymphodepletion-A Phase 2, Prospective Interventional StudyRon Ram, Odelia Amit, Chava Perry, et al.
European Journal of Haematology|February 13, 2026
Platelet and Fibrinogen Dynamics After CAR-T Cell Therapy in Relapsed/Refractory B-Cell Lymphoma May Predict ICANS OnsetHazim Khatib, Amit Parizat, Jabour Halloun, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|January 14, 2024
SCMR expert consensus statement for cardiovascular magnetic resonance of patients with a cardiac implantable electronic deviceDaniel Kim, Jeremy D Collins, James A White, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 8, 2025
High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC Working Group on Cardiovascular SurgeryAndreas Schäfer, Mirvat Alasnag, Daniele Giacoppo, et al.
American Heart Journal|September 4, 2020
New-generation drug-eluting coronary stents in octogenarians: Patient-level pooled analysis from the TWENTE I-IV trialsEline H Ploumen, Rosaly A Buiten, Carine J M Doggen, et al.
Bone Marrow Transplantation|February 1, 2025
Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphomaMagdalena Corona, Andrew Ip, Samantha Brown, et al.
British Journal of Haematology|July 1, 2025
Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experienceGiulio Cassanello, Efrat Luttwak, Samantha Brown, et al.
Transplantation and Cellular Therapy|May 24, 2026
Impact of ASTCT toxicity grading system on outcomes after CAR-T for mature B-cell malignanciesMarina Gomez-Llobell, Silvia Escribano Serrat, Maria Bromberg, et al.
Haematologica|December 24, 2025
Locally manufactured versus commercial CAR T therapy for large B-cell lymphoma : a multi-center propensity score-matched analysisRonit Marcus, Abraham Avigdor, Uri Greenbaum, et al.
Blood Advances|August 15, 2025
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphomaXavier Deschênes-Simard, Maria Bromberg, Sean M Devlin, et al.
Pageof 66